1) Thoracicoabdominal fluid
胸腹腔渗漏液
2) pleural effusion
胸腔渗出液
1.
Expression of MMP-2 and E-cadherin in primary lesions and pleural effusions of pulmonary adenocarcinoma;
肺腺癌原发灶及其胸腔渗出液中MMP-2、E-cadherin和β-catenin的表达
3) pleurorrhea
[,pluərə'ri:ə]
胸膜腔渗液
4) malignant hydrothorax and seroperitoneum
恶性胸腹腔积液
1.
Intracavitary perfusing chemotherapy combined with WBH for patients with malignant hydrothorax and seroperitoneum;
腔内灌注化疗联合全身热疗治疗恶性胸腹腔积液临床研究
5) malignant pleural effusion and ascites
癌性胸/腹腔积液
1.
Methods: 125 Ser-rhIL-2 was administered subcutaneuously or intracavitarily in patients with advanced renal cell carcinoma, malignant melanoma or malignant pleural effusion and ascites.
其中癌性胸/腹腔积液和实体瘤患者分别为 141和 31例 ,有效率分别为 80 。
6) transudatory hydrothorax
漏出性胸腔积液
1.
Objective: To analyze the cases of transudatory hydrothorax(TH) in order to improve its diagnostic rate.
目的:为了提高漏出性胸腔积液的诊断率对其进行病因分析。
补充资料：腹腔渗出液细胞
腹腔渗出液细胞
存在于腹腔渗出液中的任何细胞。渗出液中细胞数多而以中性粒细胞为主者，见于急性化脓性炎症或结核感染初期；细胞数多而淋巴细胞为主者，见于慢性炎症和结核性病变；若嗜酸性细胞增多者，见于过敏性疾病和寄生虫病。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条